At the news
? BULLISHIMPACT 5/10 8-K filed Nov 4, 2026 at 16:15 ET
Ardent Health reported Q3 2026 revenue of $1.625B (+3.1% YoY) and GAAP diluted EPS of $0.31, compared to a net loss of $0.17 per share in Q3 2025. The company raised its full-year 2026 Adjusted EBITDA guidance midpoint by 1.5% to $500-$535 million, while reaffirming revenue guidance of $6.4B-$6.7B. Adjusted EBITDA was $138M, up from $45M in the prior year quarter, driven by IMPACT program savings and volume improvement.
- Q3 2026 total revenue $1.625B, up 3.1% YoY from $1.577B
- GAAP diluted EPS $0.31 vs $(0.17) in Q3 2025
- Adjusted EBITDA $138M vs $45M in Q3 2025, margin expanded to 8.5% from 2.9%
- Full-year 2026 Adjusted EBITDA guidance raised to $500-$535M from $485-$535M
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access